These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Ratio of lethal and edema factors in rabbit systemic anthrax. Molin FD; Fasanella A; Simonato M; Garofolo G; Montecucco C; Tonello F Toxicon; 2008 Dec; 52(7):824-8. PubMed ID: 18812184 [TBL] [Abstract][Full Text] [Related]
43. Anthrax lethal toxin has direct and potent inhibitory effects on B cell proliferation and immunoglobulin production. Fang H; Xu L; Chen TY; Cyr JM; Frucht DM J Immunol; 2006 May; 176(10):6155-61. PubMed ID: 16670324 [TBL] [Abstract][Full Text] [Related]
44. Role of chondroitin sulfate C in the action of anthrax toxin. Ahn HC; Kim NY; Hur GH; Yang JM; Shin S Toxicology; 2012 Jul; 297(1-3):10-6. PubMed ID: 22503668 [TBL] [Abstract][Full Text] [Related]
46. Protection from anthrax toxin-mediated killing of macrophages by the combined effects of furin inhibitors and chloroquine. Komiyama T; Swanson JA; Fuller RS Antimicrob Agents Chemother; 2005 Sep; 49(9):3875-82. PubMed ID: 16127065 [TBL] [Abstract][Full Text] [Related]
47. LRP6 mediates Wnt/β-catenin signaling and regulates adipogenic differentiation in human mesenchymal stem cells. Peröbner I; Karow M; Jochum M; Neth P Int J Biochem Cell Biol; 2012 Nov; 44(11):1970-82. PubMed ID: 22871567 [TBL] [Abstract][Full Text] [Related]
48. Mouse susceptibility to anthrax lethal toxin is influenced by genetic factors in addition to those controlling macrophage sensitivity. Moayeri M; Martinez NW; Wiggins J; Young HA; Leppla SH Infect Immun; 2004 Aug; 72(8):4439-47. PubMed ID: 15271901 [TBL] [Abstract][Full Text] [Related]
49. Truncated mutants of the putative Wnt receptor LRP6/Arrow can stabilize beta-catenin independently of Frizzled proteins. Brennan K; Gonzalez-Sancho JM; Castelo-Soccio LA; Howe LR; Brown AM Oncogene; 2004 Jun; 23(28):4873-84. PubMed ID: 15064719 [TBL] [Abstract][Full Text] [Related]
50. A new triple chimeric protein as a high immunogenic antigen against anthrax toxins: theoretical and experimental analyses. Abdous M; Hasannia S; Salmanian AH; Shahryar Arab S; Shali A; Alizadeh GA; Hajizadeh A; Khafri A; Mohseni A Immunopharmacol Immunotoxicol; 2019 Feb; 41(1):25-31. PubMed ID: 30621469 [No Abstract] [Full Text] [Related]
51. A Diverse Set of Single-domain Antibodies (VHHs) against the Anthrax Toxin Lethal and Edema Factors Provides a Basis for Construction of a Bispecific Agent That Protects against Anthrax Infection. Vrentas CE; Moayeri M; Keefer AB; Greaney AJ; Tremblay J; O'Mard D; Leppla SH; Shoemaker CB J Biol Chem; 2016 Oct; 291(41):21596-21606. PubMed ID: 27539858 [TBL] [Abstract][Full Text] [Related]
52. Anthrax Edema and Lethal Toxins Differentially Target Human Lung and Blood Phagocytes. Patel VI; Booth JL; Dozmorov M; Brown BR; Metcalf JP Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32698436 [No Abstract] [Full Text] [Related]
53. The cytotoxic effect of anthrax lethal toxin on human lung cells in vitro and the protective action of bovine antibodies to PA and LF. Paddle BM; Wong VK; Muller BD J Appl Toxicol; 2006; 26(2):162-8. PubMed ID: 16278807 [TBL] [Abstract][Full Text] [Related]
54. Role of a Small Molecule in the Modulation of Cell Death Signal Transduction Pathways. Hartmann S; Nusbaum DJ; Kim K; Alameh S; Ho CC; Cruz RL; Levitin A; Bradley KA; Martchenko M ACS Infect Dis; 2018 Dec; 4(12):1746-1754. PubMed ID: 30354048 [TBL] [Abstract][Full Text] [Related]
55. Oxidized ATP protection against anthrax lethal toxin. Moayeri M; Wickliffe KE; Wiggins JF; Leppla SH Infect Immun; 2006 Jul; 74(7):3707-14. PubMed ID: 16790743 [TBL] [Abstract][Full Text] [Related]